Cargando…

Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance

Detalles Bibliográficos
Autores principales: Niu, Huanmin, Qian, Lilin, Luo, Yanhai, Wang, Fang, Zheng, Hongbo, Gao, Yanhui, Wang, Hanbo, Hu, Xuelei, Yuan, Huiqing, Lou, Hongxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184988/
https://www.ncbi.nlm.nih.gov/pubmed/34099617
http://dx.doi.org/10.1038/s41392-021-00547-x
_version_ 1783704690341445632
author Niu, Huanmin
Qian, Lilin
Luo, Yanhai
Wang, Fang
Zheng, Hongbo
Gao, Yanhui
Wang, Hanbo
Hu, Xuelei
Yuan, Huiqing
Lou, Hongxiang
author_facet Niu, Huanmin
Qian, Lilin
Luo, Yanhai
Wang, Fang
Zheng, Hongbo
Gao, Yanhui
Wang, Hanbo
Hu, Xuelei
Yuan, Huiqing
Lou, Hongxiang
author_sort Niu, Huanmin
collection PubMed
description
format Online
Article
Text
id pubmed-8184988
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81849882021-06-11 Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance Niu, Huanmin Qian, Lilin Luo, Yanhai Wang, Fang Zheng, Hongbo Gao, Yanhui Wang, Hanbo Hu, Xuelei Yuan, Huiqing Lou, Hongxiang Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-06-07 /pmc/articles/PMC8184988/ /pubmed/34099617 http://dx.doi.org/10.1038/s41392-021-00547-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Niu, Huanmin
Qian, Lilin
Luo, Yanhai
Wang, Fang
Zheng, Hongbo
Gao, Yanhui
Wang, Hanbo
Hu, Xuelei
Yuan, Huiqing
Lou, Hongxiang
Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance
title Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance
title_full Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance
title_fullStr Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance
title_full_unstemmed Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance
title_short Targeting of VPS18 by the lysosomotropic agent RDN reverses TFE3-mediated drug resistance
title_sort targeting of vps18 by the lysosomotropic agent rdn reverses tfe3-mediated drug resistance
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184988/
https://www.ncbi.nlm.nih.gov/pubmed/34099617
http://dx.doi.org/10.1038/s41392-021-00547-x
work_keys_str_mv AT niuhuanmin targetingofvps18bythelysosomotropicagentrdnreversestfe3mediateddrugresistance
AT qianlilin targetingofvps18bythelysosomotropicagentrdnreversestfe3mediateddrugresistance
AT luoyanhai targetingofvps18bythelysosomotropicagentrdnreversestfe3mediateddrugresistance
AT wangfang targetingofvps18bythelysosomotropicagentrdnreversestfe3mediateddrugresistance
AT zhenghongbo targetingofvps18bythelysosomotropicagentrdnreversestfe3mediateddrugresistance
AT gaoyanhui targetingofvps18bythelysosomotropicagentrdnreversestfe3mediateddrugresistance
AT wanghanbo targetingofvps18bythelysosomotropicagentrdnreversestfe3mediateddrugresistance
AT huxuelei targetingofvps18bythelysosomotropicagentrdnreversestfe3mediateddrugresistance
AT yuanhuiqing targetingofvps18bythelysosomotropicagentrdnreversestfe3mediateddrugresistance
AT louhongxiang targetingofvps18bythelysosomotropicagentrdnreversestfe3mediateddrugresistance